HOXA9 was found to be amplified in 31% (114/372) of GBM patients (Figure 1C), of which only 7.9% (9/114) presented high levels of HOXA9 mRNA (p = 0.548, Chi-square test). The gene discussed is HOXA9; the disease is glioblastoma.